Literature DB >> 32778603

Investigation and management of erythrocytosis.

Siraj Mithoowani1, Marissa Laureano1, Mark A Crowther1, Christopher M Hillis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32778603      PMCID： PMC7829024          DOI： 10.1503/cmaj.191587

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  39 in total

1.  Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project.

Authors:  Giovanni Barosi; Ruben Mesa; Guido Finazzi; Claire Harrison; Jean-Jacques Kiladjian; Eva Lengfelder; Mary F McMullin; Francesco Passamonti; Alessandro M Vannucchi; Carlos Besses; Heinz Gisslinger; Jan Samuelsson; Srdan Verstovsek; Ronald Hoffman; Animesh Pardanani; Francisco Cervantes; Ayalew Tefferi; Tiziano Barbui
Journal:  Blood       Date:  2013-04-16       Impact factor: 22.113

Review 2.  How I treat polycythemia vera.

Authors:  Jerry L Spivak
Journal:  Blood       Date:  2019-05-31       Impact factor: 22.113

3.  Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia.

Authors:  Maria Messinezy; Nigel B Westwood; Ihab El-Hemaidi; Joanne T Marsden; Roy S Sherwood; Thomas C Pearson
Journal:  Br J Haematol       Date:  2002-04       Impact factor: 6.998

4.  Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

Authors:  Alessandro M Vannucchi; Jean Jacques Kiladjian; Martin Griesshammer; Tamas Masszi; Simon Durrant; Francesco Passamonti; Claire N Harrison; Fabrizio Pane; Pierre Zachee; Ruben Mesa; Shui He; Mark M Jones; William Garrett; Jingjin Li; Ulrich Pirron; Dany Habr; Srdan Verstovsek
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

5.  Testosterone use causing erythrocytosis.

Authors:  Andrea Cervi; Amaris K Balitsky
Journal:  CMAJ       Date:  2017-10-16       Impact factor: 8.262

Review 6.  From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.

Authors:  S M Fruchtman; K Mack; M E Kaplan; P Peterson; P D Berk; L R Wasserman
Journal:  Semin Hematol       Date:  1997-01       Impact factor: 3.851

7.  Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study.

Authors:  Francesco Passamonti; Martin Griesshammer; Francesca Palandri; Miklos Egyed; Giulia Benevolo; Timothy Devos; Jeannie Callum; Alessandro M Vannucchi; Serdar Sivgin; Caroline Bensasson; Mahmudul Khan; Nadjat Mounedji; Guray Saydam
Journal:  Lancet Oncol       Date:  2016-12-02       Impact factor: 41.316

Review 8.  The complete evaluation of erythrocytosis: congenital and acquired.

Authors:  M M Patnaik; A Tefferi
Journal:  Leukemia       Date:  2009-03-19       Impact factor: 11.528

Review 9.  Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.

Authors:  Jasper H Smalberg; Lidia R Arends; Dominique C Valla; Jean-Jacques Kiladjian; Harry L A Janssen; Frank W G Leebeek
Journal:  Blood       Date:  2012-10-04       Impact factor: 22.113

Review 10.  Laboratory Investigation of Myeloproliferative Neoplasms (MPNs):  Recommendations of the Canadian Mpn Group.

Authors:  Lambert Busque; Anna Porwit; Radmila Day; Harold J Olney; Brian Leber; Vincent Éthier; Shireen Sirhan; Linda Foltz; Jaroslav Prchal; Suzanne Kamel-Reid; Aly Karsan; Vikas Gupta
Journal:  Am J Clin Pathol       Date:  2016-10       Impact factor: 2.493
View more
  11 in total

1.  Erythrocytosis induced by sodium-glucose cotransporter-2 inhibitors.

Authors:  Benjamin Chin-Yee; Ziad Solh; Cyrus Hsia
Journal:  CMAJ       Date:  2020-10-19       Impact factor: 8.262

2.  Clinical Characteristics of Pediatric Patients with Congenital Erythrocytosis: A Single-Center Study.

Authors:  Sema Aylan Gelen; Nazan Sarper; Emine Zengin; İnci Tahsin; Mehmet Azizoğlu
Journal:  Indian J Hematol Blood Transfus       Date:  2021-08-25       Impact factor: 0.900

3.  The Gaisbock syndrome after COVID-19 pneumonia.

Authors:  Abbie Evans; Busara Songtanin; Kenneth Nugent
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-01-13

4.  Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy.

Authors:  Kamilya A Schumacher; Aidar R Gosmanov
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

5.  Polycythemia-Related Proliferative Ischemic Retinopathy Managed with Smoking Cessation: A Case Report.

Authors:  Shao-Yu Sung; Yo-Chen Chang; Horng-Jiun Wu; Hung-Chi Lai
Journal:  Int J Environ Res Public Health       Date:  2022-06-30       Impact factor: 4.614

6.  Causes of erythrocytosis and its impact as a risk factor for thrombosis according to etiology: experience in a referral center in Mexico City.

Authors:  Antonio Olivas-Martinez; Eduardo Corona-Rodarte; Adrián Nuñez-Zuno; Olga Barrales-Benítez; Daniel Montante-Montes de Oca; Jesús Delgado-de la Mora; Diana León-Aguilar; Hilda Elizeth Hernández-Juárez; Elena Tuna-Aguilar
Journal:  Blood Res       Date:  2021-09-30

7.  Acute Lower Extremity Arterial Thrombosis Associated with Osimertinib-Induced Erythrocytosis.

Authors:  Shota Kodaira; Jun Ehara; Shigemasa Takamizawa; Shin Ogita; Yasuhiro Norisue; Tatsuya Nakama; Eiji Hiraoka
Journal:  Am J Case Rep       Date:  2021-09-07

8.  Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort study.

Authors:  Sirak Tesfamariam; Amon Solomon Ghebrenegus; Henok Woldu; Ephrem Fisseha; Gebremeskel Belai; Mulugeta Russom
Journal:  BMJ Open Respir Res       Date:  2021-11

9.  Potential limitations of diagnostic standard codes to distinguish polycythemia vera and secondary erythrocytosis.

Authors:  Alanna Barrios-Ruiz; Daniel Davila-Gonzalez; Eric Fountain; Lee Cheng; Srdan Verstovsek; Cristhiam M Rojas-Hernandez
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.379

10.  Obstructive Sleep Apnea is Associated with an Increased Prevalence of Polycythemia in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Zhaofu Zeng; Yan Song; Xin He; Haizhen Yang; Fang Yue; Mengqing Xiong; Ke Hu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.